This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the ROTATEQ vaccine, a 2-milliliter vaccine, with a ceiling value of $3,155.18 and a period of performance through December 23, 2024.
The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.
This contract award does not have a set-aside designation, indicating open competition. It is one of several federal contract awards that AmerisourceBergen has received from the DLA and other government agencies, demonstrating the company's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.
Generated 3/21/25, 9:56 AM